|
Oct 9
|
Ligand Pharmaceuticals Inc (LGND) Q2 2024 Earnings Call Highlights: Robust Revenue Growth Amid ...
|
|
Oct 9
|
LGND: Initiating Coverage – A Prince Among Royalty
|
|
Aug 27
|
Insider Sale: President & COO Matthew Korenberg Sells 18,858 Shares of Ligand ...
|
|
Aug 10
|
Insider Buying: CEO Todd Davis Acquires Shares of Ligand Pharmaceuticals Inc (LGND)
|
|
Aug 8
|
Ligand Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Aug 7
|
How These Two Lesser-Known Biotech Names Obliterated Sales Expectations
|
|
Aug 6
|
Ligand: Q2 Earnings Snapshot
|
|
Aug 6
|
Ligand Reports Second Quarter 2024 Financial Results
|
|
Jul 30
|
Hidden Gems Undiscovered Companies with Strong Fundamentals For July 2024
|
|
Jul 30
|
Undiscovered Gems In The United States For July 2024
|
|
Jul 23
|
Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024
|
|
Jun 24
|
Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
|
|
Jun 19
|
Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?
|
|
Jun 19
|
Roche (RHHBY), Ascidian Team Up for RNA Exon Editing Therapeutics
|
|
Jun 19
|
The past three years for Ligand Pharmaceuticals (NASDAQ:LGND) investors has not been profitable
|
|
Jun 18
|
Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults
|
|
Feb 16
|
Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires
|
|
Feb 13
|
Ligand to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
|
|
Feb 12
|
Here's Why Ligand Pharmaceuticals (LGND) Fell More Than Broader Market
|
|
Jan 11
|
Ligand Pharmaceuticals (LGND) Suffers a Larger Drop Than the General Market: Key Insights
|